Talk:Oxymorphazone: Difference between revisions
>Khuntosaurusrex More done |
>Khuntosaurusrex Legal changes |
||
Line 46: | Line 46: | ||
|OralROA=true | |OralROA=true | ||
|OralROA_Collapsed=false | |OralROA_Collapsed=false | ||
|OralROA_Bioavailability= | |||
|OralROA_Caption= | |OralROA_Caption= | ||
|OralROA_Microdose= | |OralROA_Microdose= | ||
|OralROA_Threshold=[[ | |OralROA_Threshold=[[1.25 - 5::x]] - [5] [[Oral dose units::mg]] | ||
|OralROA_Light=[[Oral min light dose::x1]] - [[Oral max light dose::x2]] mg | |OralROA_Light=[[Oral min light dose::x1]] - [[Oral max light dose::x2]] mg | ||
|OralROA_Common=[[Oral min common dose::x1]] - [[Oral max common dose::x2]] mg | |OralROA_Common=[[Oral min common dose::x1]] - [[Oral max common dose::x2]] mg | ||
Line 88: | Line 88: | ||
==History and culture== | ==History and culture== | ||
Oxymorphazone was first synthesised in 1979 by a team of Chemists at Rockefeller University, New York. Recent attempts to build effective irreversible opioid [[agonists]] encouraged the team to develop a hydrazone derivative of oxymorphone. | Oxymorphazone was first synthesised in 1979 by a team of Chemists at Rockefeller University, New York. Recent attempts to build effective irreversible opioid [[agonists]] encouraged the team to develop a hydrazone derivative of oxymorphone. | ||
There is no documented human consumption of oxymorphazone. This is potentially due to its high addiction liability and extremely long duration. | |||
==Chemistry== | ==Chemistry== | ||
Line 160: | Line 162: | ||
==Legal status== | ==Legal status== | ||
*'''United Kingdom''' - Oxymorphone is a Class A, Schedule 2 drug in the United Kingdom. It has no medical uses. <ref>Psychoactive Substances Act 2016. (2016). Retrieved from http://www.legislation.gov.uk/ukpga/2016/2/schedule/2/enacted</ref> | |||
*'''United States''' - Oxymorphazone is a Schedule I Controlled Substance in the United States. It is considered to be unsafe and holds no medical value. <ref> Drug Enforcement Administration Controlled Substances | https://www.deadiversion.usdoj.gov/schedules/orangebook/e_cs_sched.pdf</ref> | |||
==See also== | ==See also== | ||
Line 172: | Line 176: | ||
==Literature== | ==Literature== | ||
* APA formatted reference | * APA formatted reference | ||
==References== | ==References== |